What are the gastric modifications induced by acute and chronic Helicobacter pylori infection?;Quelles sont les modifications gastriques induites par I'infection aiguë et chronique par Helicobacter pylori?

Gastroenterologie Clinique et Biologique

Volumn 27, Issue 3 II, 2003, Pages 391-400

  Lamarque, Dominique ^a   Tran Van Nhieu, Jeanne ^b   Breban, Maxime ^c  

^a BICHAT HOSPITAL   (France)

^b HENRI MONDOR HOSPITAL   (France)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACID; BACTERIUM LIPOPOLYSACCHARIDE; CYTOKINE; DNA; FREE RADICAL; GASTRIN; HISTAMINE; INTERLEUKIN 1; INTERLEUKIN 1BETA; INTERLEUKIN 8; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN SYNTHASE; PROTEIN P53; SOMATOSTATIN; TOXIN; TUMOR NECROSIS FACTOR; UREASE; VIRULENCE FACTOR;

ACHLORHYDRIA; ACID SECRETION; APOPTOSIS; ATROPHIC GASTRITIS; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIUM ADHERENCE; CANCER; CARCINOGENESIS; CELL ACTIVATION; CELL PROLIFERATION; CELL TYPE; CHORION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EPITHELIUM; EPITHELIUM CELL; GASTRITIS; GENOTYPE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HORMONE RELEASE; HOST; IMMUNE RESPONSE; INFLAMMATION; INFLAMMATORY CELL; LYMPHOCYTE; MEAL; MISMATCH REPAIR; MONOCYTE; MUTAGENICITY; NONHUMAN; PATHOGENICITY; PROTEIN EXPRESSION; REVIEW; STOMACH PARIETAL CELL; TH1 CELL;

APOPTOSIS; ATROPHY; CYTOKINES; DNA DAMAGE; DNA REPAIR; GASTRIC ACID; GASTRIC MUCOSA; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INFLAMMATION; INTERLEUKIN-8; LYMPHOCYTES;

EID: 0037362185     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (123)

1. Clyne M, Drumm B. Absence of effect of Lewis A and Lewis B expression on adherence of Helicobacter pylori to human gastric cells. Gastroenterology 1997;113:72-80.
2. Wirth HP, Yang M, Peek RM Jr., Tham KT, Blaser MJ. Helicobacter pylori Lewis expression is related to the host Lewis phenotype. Gastroenterology 1997;113:1091-8.
3. Moran AP, Knirel YA, Senchenkova SN, Widmalm G, Hynes SO et al. Phenotypic variation in molecular mimicry between Helicobacter pylori lipopolysaccharides and human gastric epithelial cell surface glycoforms. Acid-induced phase variation in Lewis (X) and Lewis (Y) expression by H. pylori lipopolysaccharides. J Biol Chem 2002;277:5785-95.
4. Mahdavi J, Sonden B, Hurtig M, Olfat FO, Forsberg L, Roche N et al. Helicobacter pylori SabA adhesin in persistent infection and chronic inflammation. Science 2002;297:573-8.
5. Gerhard M, Lehn N, Neumayer N, Boren T, Rad R, Schepp W et al. Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin. Proc Natl Acad Sci USA 1999;96:12778-83.
6. Rad R, Gerhard M, Lang R, Schoniger M, Rosch T, Schepp W et al. The Helicobacter pylori blood group - antigen-binding adhesin facilitates bacterial colonization and augments a nonspecific immune response. J Immunol 2002;168:3033-41.
7. Fan X, Crowe SE, Behar S, Gunasena H, Ye G, Haeberle H et al. The effect of class II major histocompatibility complex expression on adherence of Helicobacter pylori and induction of apoptosis in gastric epithelial cells: a mechanism for T helper cell type 1-mediated damage. J Exp Med 1998;187:1659-69.
8. Haeberle HA, Kubin M, Bamford KB, Garofalo R, Graham DY, ElZaatari F et al. Differential stimulation of interleukin-12 (IL-12) and IL-10 by live and killed Helicobacter pylori in vitro and association of IL-12 production with gamma interferon-producing T cells in the human gastric mucosa. Infect Immun 1997;65:4229-35.
9. Maekawa T, Kinoshita Y, Matsushima Y, Okada A, Fukui H, Waki S et al. Helicobacter pylori induces proinflammatory cytokines and major histocompatibility complex class II antigen in mouse gastric epithelial cells. J Lab Clin Med 1997;130:442-9.
10. Watanabe N, Shimada T, Ohtsuka Y, Hiraishi H, Terano A. Proinflammatory cytokines and Helicobacter pylori stimulate CC-chemokine expression in gastric epithelial cells. J Physiol Pharmacol 1997;48:405-13.
11. Rieder G, Hatz RA, Moran AP, Walz A, Stolte M, Enders G. Role of adherence in interleukin-8 induction in Helicobacter pylori-associated gastritis. Infect Immun 1997;65:3622-30.
12. Odenbreit S, Puls J, Sedlmaier B, Gerland E, Fischer W, Haas R. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science 2000;287:1497-500.
13. Yeo HJ, Savvides SN, Herr AB, Lanka E, Waksman G. Crystal structure of the hexameric traffic ATPase of the Helicobacter pylori type IV secretion system. Mol Cell 2000;6:1461-72.
14. Naumann M, Wessler S, Bartsch C, Wieland B, Covacci A, Haas R et al. Activation of activator protein I and stress response kinases in epithelial cells colonized by Helicobacter pylori encoding the cag pathogenicity island. J Biol Chem 1999;274:31655-62.
15. Glocker E, Lange C, Covacci A, Bereswill S, Kist M, Pahl HL. Proteins encoded by the cag pathogenicity island of Helicobacter pylori are required for NF-kappaB activation. Infect Immun 1998;66:2346-8.
16. Audibert C, Burucoa C, Janvier B, Fauchère JL. implication of the structure of the Helicobacter pylori cag pathogenicity island in induction of interleukin-8 secretion. Infect Immun 2001;69:1625-9.
17. Israel DA, Salama N, Arnold CN, Moss SF, Ando T, Wirth HP et al. Helicobacter pylori strain-specific differences in genetic content, identified by microarray, influence host inflammatory responses. J Clin Invest 2001;107:611-20.
18. Yamaoka Y, Kwon DH, Graham DY. A M(r) 34,000 proinflammatory outer membrane protein (oipA) of Helicobacter pylori. Proc Natl Acad Sci USA 2000;97:7533-8.
19. Ando T, Kusugami K, Ohsuga M, Ina K, Shinoda M, Konagaya T et al. Differential normalization of mucosal interleukin-8 and interleukin-6 activity after Helicobacter pylori eradication. Infect Immun 1998;66:4742-7.
20. Hatz RA, Rieder G, Stolte M, Bayerdorffer E, Meimarakis G, Schildberg FW et al. Pattern of adhesion molecule expression on vascular endothelium in Helicobacter pylori-associated antral gastritis. Gastroenterology 1997;112:1908-19.
21. Hansen PS, Madsen PH, Petersen SB, Nielsen H. Inflammatory activation of neutrophils by Helicobacter pylori: a mechanism insensitive to pertussis toxin. Clin Exp Immunol 2001;123:73-80.
22. Bliss CM Jr., Golenbock DT, Keates S, Linevsky JK, Kelly CP. Helicobacter pylori lipopolysaccharide binds to CD14 and stimulates release of interleukin-8, epithelial neutrophil-activating peptide 78, and monocyte chemotactic protein I by human monocytes. Infect Immun 1998;66:5357-63.
23. Kwon DH, Woo JS, Perng CL, Go MF, Graham DY, El-Zaatari FA. The effect of gale gene inactivation on lipopolysaccharide profile of Helicobacter pylori. Curr Microbiol 1998;37:144-8.
24. Yoshida M, Wakatsuki Y, Kobayashi Y, Itoh T, Murakami K, Mizoguchi A et al. Cloning and characterization of a novel membrane-associated antigenic protein of Helicobacter pylori. Infect Immun 1999;67:286-93.
25. Evans DJ Jr., Evans DG, Takemura T, Nakano H, Lampert HC, Graham DY et al. Characterization of a Helicobacter pylori neutrophil-activating protein. Infect Immun 1995;63:2213-20.
26. Harris PR, Ernst PB, Kawabata S, Kiyono H, Graham MF, Smith PD. Recombinant Helicobacter pylori urease activates primary mucosal macrophages. J Infect Dis 1998;178:1516-20.
27. Aihara M, Imagawa K, Funakoshi Y, Ohmoto Y, Kikuchi M. Effects of rebamipide on production of several cytokines by human peripheral blood mononuclear cells. Dig Dis Sci 1998;43:160S-6S.
28. Eaton KA, Ringler SR, Danon SJ. Murine splenocytes induce severe gastritis and delayed-type hypersensitivity and suppress bacterial colonization in Helicobacter pylori-infected SCID mice. Infect Immun 1999;67:4594-602.
29. Barrera C, Espejo R, Reyes VE. Differential glycosylation of MHC class II molecules on gastric epithelial cells: implications in local immune responses. Hum Immunol 2002;63:384-93.
30. Engstrand L, Graham D, Scheynius A, Genta RM, El-Zaatari F. Is the sanctuary where Helicobacter pylori avoids antibacterial treatment intracellular? Am J Clin Pathol 1997;108:504-9.
31. Tomita T, Jackson AM, Hida N, Hayat M, Dixon MF, Shimoyama T et al. Expression of Interleukin-18, a Thcytokine, in human gastric mucosa is increased in Helicobacter pylori infection. J Infect Dis 2001;183:620-7.
32. Bauditz J, Ortner M, Bierbaum M, Niedobitek G, Lochs H, Schreiber S. Production of IL-12 in gastritis relates to infection with Helicobacter pylori. Clin Exp Immunol 1999;117:316-23.
33. D'Elios MM, Manghetti M, Almerigogna F, Amedei A, Costa F, Burroni D et al. Different cytokine profile and antigen-specificity repertoire in Helicobacter pylori-specific T cell clones from the antrum of chronic gastritis patients with or without peptic ulcer. Eur J Immunol 1997;27:1751-5.
34. Bamford KB, Fan X, Crowe SE, Leary JF, Gourley WK, Luthra GK et al. Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype. Gastroenterology 1998;114:482-92.
35. Mattapallil JJ, Dandekar S, Canfield DR, Solnick JV. A predominant Th1 type of immune response is induced early during acute Helicobacter pylori infection in rhesus macaques. Gastroenterology 2000;118:307-15.
36. Keates S, Hitti YS, Upton M, Kelly CP. Helicobacter pylori infection activates NF-kappa B in gastric epithelial cells. Gastroenterology 1997;113:1099-109.
37. Crabtree JE. Role of cytokines in pathogenesis of Helicobacter-pylori-induced mucosal damage. Dig Dis Sci 1998;43:46S-55S.
38. Munzenmaier A, Lange C, Glocker E, Covacci A, Moran A, Bereswill S et al. A secreted/shed product of Helicobacter pylori activates transcription factor nuclear factor-kappa B. J Immunol 1997;159:6140-7.
39. Mori N, Ueda A, Geleziunas R, Wada A, Hirayama T, Yoshimura T et al. Induction of monocyte chemoattractant protein by Helicobacter pylori involves NF-kappaB. Infect Immun 2001;69:1280-6.
40. Sutton P, Kolesnikow T, Danon S, Wilson J, Lee A. Dominant nonresponsiveness to Helicobacter pylori infection is associated with production of interleukin 10 but not gamma interferon. Infect Immun 2000;68:4802-4.
41. El-Omar EM, Wang CD, McColl KE, Rabkin CS. Interleukin-10 promoter polymorphisms influence risk of chronic H. pylori infection (abstract). Gastroenterology 2000;118:A889.
42. El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000;404:398-402.
43. Yamaoka Y, Kita M, Kodama T, Sawai N, Kashima K, Imanishi J. Induction of various cytokines and development of severe mucosal inflammation by cagA gene positive Helicobacter pylori strains. Gut 1997;41:442-51.
44. Sharma SA, Tummuru MK, Blaser MJ, Kerr LD. Activation of IL-8 gene expression by Helicobacter pylori is regulated by transcription factor nuclear factor-kappa B in gastric epithelial cells. J Immunol 1998;160:2401-7.
45. Karita M, Tummuru MK, Wirth HP, Blaser MJ. Effect of growth phase and acid shock on Helicobacter pylori cagA expression. Infect Immun 1996;64:4501-7.
46. Blaser MJ, Berg DE. Helicobacter pylori genetic diversity and risk of human disease. J Clin Invest 2001;107:767-73.
47. Xu Q, Morgan RD, Roberts RJ, Blaser MJ. Identification of type II restriction and modification systems in Helicobacter pylori reveals their substantial diversity among strains. Proc Natl Acad Sci USA 2000;97:9671-6.
48. Wang J, Brooks EG, Bamford KB, Denning TL, Pappo J, Ernst PB. Negative selection of T cells by Helicobacter pylori as a model for bacterial strain selection by immune evasion. J Immunol 2001;167:926-34.
49. Gobert AP, McGee DJ, Akhtar M, Mendz GL, Newton JC, Cheng Y et al. Helicobacter pylori arginase inhibits nitric oxide production by eukaryotic cells: a strategy for bacterial survival. Proc Natl Acad Sci USA 2001;98:13844-9.
50. Allen LA, Schlesinger LS, Kang B. Virulent strains of Helicobacter pylori demonstrate delayed phagocytosis and stimulate homotypic phagosome fusion in macrophages. J Exp Med 2000;191:115-28.
51. Hofman V, Ricci V, Mograbi B, Brest P, Luciano F, Boquet P et al. Helicobacter pylori lipopolysaccharide hinders polymorphonuclear leucocyte apoptosis. Lab Invest 2001;81:375-84.
52. Nolan KJ, McGee DJ, Mitchell HM, Kolesnikow T, Harro JM, O'Rourke J et al. In vivo behavior of a Helicobacter pylori SS1 nixA mutant with reduced urease activity. Infect Immun 2002;70:685-91.
53. Debellis L, Papini E, Caroppo R, Montecucco C, Curci S. Helicobacter pylori cytotoxin VacA increases alkaline secretion in gastric epithelial cells. Am J Physiol Gastrointest Liver Physiol 2001;281:G1440-8.
54. Yamaoka Y, Kikuchi S, El-Zimaity HM, Gutierrez O, Osato MS, Graham DY. Importance of Helicobacter pylori oipA in clinical presentation, gastric inflammation, and mucosal interleukin 8 production. Gastroenterology 2002;123:414-24.
55. Correa P, Miller MJ. Carcinogenesis, apoptosis and cell proliferation. Br Med Bull 1998;54:151-62.
56. Moss SF, Calam J, Agarwal B, Wang S, Holt PR. Induction of gastric epithelial apoptosis by Helicobacter pylori. Gut 1996;38:498-501.
57. Nogueira C, Figueiredo C, Carneiro F, Gomes AT, Barreira R, Figueira P et al. Helicobacter pylori genotypes may determine gastric histopathology. Am J Pathol 2001;158:647-54.
58. Kawahara T, Teshima S, Kuwano Y, Oka A, Kishi K, Rokutan K. Helicobacter pylori lipopolysaccharide induces apoptosis of cultured guinea pig gastric mucosal cells. Am J Physiol Gastrointest Liver Physiol 2001;281:G726-34.
59. Suzuki H, Yanaka A, Shibahara T, Matsui H, Nakahara A, Tanaka N et al. Ammonia-induced apoptosis is accelerated at higher pH in gastric surface mucous cells. Am J Physiol Gastrointest Liver Physiol 2002;283:G986-95.
60. Igarashi M, Kitada Y, Yoshiyama H, Takagi A, Miwa T, Koga Y. Ammonia as an accelerator of tumor necrosis factor alpha-induced apoptosis of gastric epithelial cells in Helicobacter pylori infection. Infect Immun 2001;69:816-21.
61. Wagner S, Beil W, Westermann J, Logan RP, Bock CT, Trautwein C et al. Regulation of gastric epithelial cell growth by Helicobacter pylori: Evidence for a major role of apoptosis. Gastroenterology 1997;113:1836-47.
62. Hahm KB, Lee KJ, Choi SY, Kim JH, Cho SW, Yim H et al. Possibility of chemoprevention by the eradication of Helicobacter pylori: oxidative DNA damage and apoptosis in H. pylori infection. Am J Gastroenterol 1997;92:1853-7.
63. Mannick EE, Bravo LE, Zarama G, Realpe JL, Zhang XJ, Ruiz B et al. Inducible nitric oxide synthase, nitrotyrosine, and apoptosis in Helicobacter pylori gastritis: effect of antibiotics and antioxidants. Cancer Res 1996;56:3238-43.
64. Suzuki M, Miura S, Suematsu M, Fukumura D, Kurose I, Suzuki H et al. Helicobacter pylori-associated ammonia production enhances neutrophil-dependent gastric mucosal cell injury. Am J Physiol 1992;263:G719-25.
65. Nardone G, Staibano S, Rocco A, Mezza E, D'Armiento F P, Insabato L et al. Effect of Helicobacter pylori infection and its eradication on cell proliferation, DNA status, and oncogene expression in patients with chronic gastritis. Gut 1999;44:789-99.
66. Suzuki H, Miyazawa M, Kai A, Suzuki M, Suematsu M, Miura S et al. No difference in the level of gastric mucosal cell apoptosis and proliferation in Helicobacter pylori-colonized p53 heterozygous knockout mice. Aliment Pharmacol Ther 2002;16:158-66.
67. Jones NL, Day AS, Jennings HA, Sherman PM. Helicobacter pylori induces gastric epithelial cell apoptosis in association with increased Fas receptor expression. Infect Immun 1999;67:4237-42.
68. Rudi J, Kuck D, Strand S, von Herbay A, Mariani SM, Krammer PH et al. Involvement of the CD95 (APO-1/Fas) receptor and ligand system in Helicobacter pylori-induced gastric epithelial apoptosis. J Clin Invest 1998;102:1506-14.
69. D'Elios MM, Bergman MP, Azzurri A, Amedei A, Benagiano M, De Pont JJ et al. H(+), K(+)-ATPase (proton pump) is the target autoantigen of Th1-type cytotoxic T cells in autoimmune gastritis. Gastroenterology 2001;120:377-86.
70. Appelmelk BJ, Faller G, Claeys D, Kirchner T, VandenbrouckeGrauls CM. Bugs on trial: the case of Helicobacter pylori and autoimmunity. Immunol Today 1998;19:296-9.
71. Ko GH, Park HB, Shin MK, Park CK, Lee JH, Youn HS et al. Monoclonal antibodies against Helicobacter pylori cross-react with human tissue. Helicobacter 1997;2:210-5.
72. Claeys D, Faller G, Appelmelk BJ, Negrini R, Kirchner T. The gastric H+, K+-ATPase is a major autoantigen in chronic Helicobacter pylori gastritis with body mucosa atrophy. Gastroenterology 1998;115:340-7.
73. Faller G, Ruff S, Reiche N, Hochberger J, Hahn EG, Kirchner T. Mucosal production of antigastric autoantibodies in Helicobacter pylori gastritis. Helicobacter 2000;5:129-34.
74. Taylor DE, Rasko DA, Sherburne R, Ho C, Jewell LD. Lack of correlation between Lewis antigen expression by Helicobacter pylori and gastric epithelial cells in infected patients. Gastroenterology 1998;115:1113-22.
75. Ricci V, Ciacci C, Zarrilli R, Sommi P, Tummuru MK, Del Vecchio Blanco C et al. Effect of Helicobacter pylori on gastric epithelial cell migration and proliferation in vitro: role of VacA and CagA. Infect Immun 1996;64:2829-33.
76. Knipp U, Birkholz S, Kaup W, Opferkuch W. Partial characterization of a cell proliferation-inhibiting protein produced by Helicobacterpylori. Infect Immun 1996;64:3491-6.
77. Fu S, Ramanujam KS, Wong A, Fantry GT, Drachenberg CB, James SP et al. Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritis. Gastroenterology 1999;116:1319-29.
78. Jackson LM, Wu KC, Mahida YR, Jenkins D, Hawkey CJ. Cyclooxygenase (COX) 1 and 2 in normal, inflamed, and ulcerated human gastric mucosa. Gut 2000;47:762-70.
79. Li J, Bombeck CA, Yang S, Kim YM, Billiar TR. Nitric oxide suppresses apoptosis via interrupting caspase activation and mitochondrial dysfunction in cultured hepatocytes. J Biol Chem 1999;274:17325-33.
80. Kim YM, Bombeck CA, Billiar TR. Nitric oxide as a bifunctional regulator of apoptosis. Circ Res 1999;84:253-6.
81. Pignatelli B, Bancel B, Plummer M, Toyokuni S, Patricot LM, Ohshima H. Helicobacter pylori eradication attenuates oxidative stress in human gastric mucosa. Am J Gastroenterol 2001;96:1758-66.
82. Forrester K, Ambs S, Lupold SE, Kapust RB, Spillare EA, Weinberg WC et al. Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53. Proc Natl Acad Sci USA 1996;93:2442-7.
83. von Knethen A, Callsen D, Brune B. Superoxide attenuates macrophage apoptosis by NF-kappa B and AP-1 activation that promotes cyclooxygenase-2 expression. J Immunol 1999;163:2858-66.
84. Pai R, Soreghan B, Szabo IL, Pavelka M, Baatar D, Tarnawski AS. Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy. Nat Med 2002;8:289-93.
85. Wambura C, Aoyama N, Shirasaka D, Sakai T, Ikemura T, Sakashita M et al. Effect of Helicobacter pylori-induced cyclooxygenase-2 on gastric epithelial cell kinetics: implication for gastric carcinogenesis. Helicobacter 2002;7:129-38.
86. Peek RM Jr., Wirth HP, Moss SF, Yang M, Abdalla AM, Tham KT et al. Helicobacter pylori alters gastric epithelial cell cycle events and gastrin secretion in Mongolian gerbils. Gastroenterology 2000;118:48-59.
87. Kim JJ, Tao H, Carloni E, Leung WK, Graham DY Sepulveda AR. Helicobacter pylori impairs DNA mismatch repair in gastric epithelial cells. Gastroenterology 2002;123:542-53.
88. Murayama Y, Miyagawa J, Shinomura Y, Kanayama S, Yasunaga Y, Nishibayashi H et al. Morphological and functional restoration of parietal cells in Helicobacter pylori associated enlarged fold gastritis after eradication. Gut 1999;45:653-61.
89. Konturek PC, Brzozowski T, Konturek SJ, Stachura J, Karczewska E, Pajdo R et al. Mouse model of Helicobacter pylori infection: studies of gastric function and ulcer healing. Aliment Pharmacol Ther 1999;13:333-46.
90. Haruma K, Kawaguchi H, Yoshihara M, Okamoto S, Sumii K, Kishimoto S et al. Relationship between Helicobacter pylori infection and gastric acid secretion in young healthy subjects. J Clin Gastroenterol 1994;19:20-2.
91. Iijima K, Ohara S, Sekine H, Koike T, Kato K, Asaki S et al. Changes in gastric acid secretion assayed by endoscopic gastrin test before and after Helicobacter pylori eradication. Gut 2000;46:20-6.
92. El-Omar EM, Oien K, El-Nujumi A, Gillen D, Wirz A, Dahill S et al. Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology 1997;113:15-24.
93. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784-9.
94. Kondo S, Shinomura Y, Kanayama S, Kawabata S, Miyazaki Y, Inamura I et al. Interleukin-1 beta inhibits gastric histamine secretion and synthesis in the rat. Am J Physiol 1994;267:G966-71.
95. Takashima M, Furuta T, Hanai H, Sugimura H, Kaneko E. Effects of Helicobacter pylori infection on gastric acid secretion and serum gastrin levels in Mongolian gerbils. Gut 2001;48:765-73.
96. Beales IL, Calam J. Interleukin beta and tumour necrosis factor alpha inhibit acid secretion in cultured rabbit parietal cells by multiple pathways. Gut 1998;42:227-34.
97. Wallace JL, Cucala M, Mugridge K, Parente L. Secretagogue-specific effects of interleukin-1 on gastric acid secretion. Am J Physiol 1991;261:G559-64.
98. Wang M, Furuta T, Takashima M, Futami H, Shirai N, Hanai H et al. Relation between interleukin-1 beta messenger RNA in gastric fundic mucosa and gastric juice pH in patients infected with Helicobacter pylori. J Gastroenterol 1999;34 Suppl 11:10-7.
99. El-Omar EM, Oien K, Murray LS, El-Nujumi A, Wirz A, Gillen D et al. Increased prevalence of precancerous changes in relatives of gastric cancer patients: critical role of Helicobacter pylori. Gastroenterology 2000;118:22-30.
100. El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000;404:398-402.
101. Furuta T, El-Omar EM, Xiao F, Shirai N, Takashima M, Sugimura H et. al. Interleukin-1 beta polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan. Gastroenterology 2002;123:92-105.
102. Chiba T, Watanabe T, Ito T. Helicobacter pylori infection and acid secretion in patients with duodenal ulcer in Japan. Gut 2001;48:871-2.
103. Faller G, Winter M, Steininger H, Konturek P, Konturek SJ, Kirchner T. Antigastric autoantibodies and gastric secretory function in Helicobacter pylori-infected patients with duodenal ulcer and nonulcer dyspepsia. Scand J Gastroenterol 1998;33:276-82.
104. Croinin TO, Clyne M, Appelmelk BJ, Drumm B. Antigastric autoantibodies in ferrets naturally infected with Helicobacter mustelae. Infect Immun 2001;69:2708-13.
105. Sobala GM, Schorah CJ, Shires S, Lynch DA, Gallacher B, Dixon MF et al. Effect of eradication of Helicobacter pylori on gastric juice ascorbic acid concentrations. Gut 1993;34:1038-41.
106. Ruiz B, Rood JC, Fontham ET, Malcom GT, Hunter FM, Sobhan M et al. Vitamin C concentration in gastric juice before and after anti-Helicobacter pylori treatment. Am J Gastroenterol 1994;89:533-9.
107. Licht WR, Tannenbaum SR, Deen WM. Use of ascorbic acid to inhibit nitrosation: kinetic and mass transfer considerations for an in vitro system. Carcinogenesis 1988;9:365-72.
108. Tannenbaum SR, Weisman M, Fett D, The effect of nitrate intake on nitrite formation in human saliva. Food Cosmet Toxicol 1976;14:549-52.
109. Xu GP, Reed P1. N-nitroso compounds in fresh gastric juice and their relation to intragastric pH and nitrite employing an improved analytical method. Carcinogenesis 1993;14:2547-51.
110. Fan TY, Tannenbaum SR. Factors influencing the rate of formation of nitrosomorpholine from morpholine and nitrite: acceleration by thiocyanate and other anions. J Agric Food Chem 1973;21:237-40.
111. Schievelbein H, Werle E, Schulz EK, Baumeister R. The influence of tobacco smoke and nicotine on thiocyanate metabolism. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol 1969;262:358-65.
112. Moss SF, Calam J. Acid secretion and sensitivity to gastrin in patients with duodenal ulcer: effect of eradication of Helicobacter pylori. Gut 1993;34:888-92.
113. El-Omar E, Penman I, Dorrian CA, Ardill JE, McColl KE. Eradicating Helicobacter pylori infection lowers gastrin mediated acid secretion by two thirds in patients with duodenal ulcer. Gut 1993;34:1060-5.
114. Lloyd KC, Wang J, Aurang K, Gronhed P, Coy DH, Walsh JH. Activation of somatostatin receptor subtype 2 inhibits acid secretion in rats. Am J Physiol 1995;268:G102-6.
115. Odum L, Petersen HD, Andersen IB, Hansen BF, Rehfeld JF. Gastrin and somatostatin in Helicobacter pylori infected antral mucosa. Gut 1994;35:615-8.
116. Moss SF, Legon S, Bishop AE, Polak JM, Calam J. Effect of Helicobacter pylori on gastric somatostatin in duodenal ulcer disease. Lancet 1992;340:930-2.
117. Queiroz DM, Moura SB, Mendes EN, Rocha GA, Barbosa AJ, de Carvalho AS. Effect of Helicobacter pylori eradication on G-cell and D-cell density in children. Lancet 1994;343:1191-3.
118. Beales I, Blaser MJ, Srinivasan S, Calam J, Perez-Perez GI, Yamada T et al. Effect of Helicobacter pylori products and recombinant cytokines on gastrin release from cultured canine G cells. Gastroenterology 1997;113:465-71.
119. Arebi N, Healey ZV, Bliss PW, Ghatei M, Van Noorden S, Playford RJ et al. Nitric oxide regulates the release of somatostatin from cultured gastric rabbit primary D-cells. Gastroenterology 2002;123:566-76.
120. Beardshall K, Moss S, Gill J, Levi S, Ghosh P, Playford RJ et al. Suppression of Helicobacter pylori reduces gastrin releasing peptide stimulated gastrin release in duodenal ulcer patients. Gut 1992;33:601-3.
121. Weigert N, Schaffer K, Schusdziarra V, Classen M, Schepp W. Gastrin secretion from primary cultures of rabbit antral G cells: stimulation by inflammatory cytokines. Gastroenterology 1996;110:147-54.
122. Beales IL, Calam J. Helicobacter pylori infection and tumour necrosis factor-alpha increase gastrin release from human gastric antral fragments. Eur J Gastroenterol Hepatol 1997;9:773-7.
123. van den Brik GR, ten Kate FJ, Ponsioen CY, Rive MM, Tytgat GN, van Deventer SJ et al. Expression and activation of NF-kappa B in the antrum of the human stomach. J Immunol 2000;164:3353-9.